Characteristics | ARDS patients (n = 40) | Healthy controls (n = 40) | P |
---|---|---|---|
Male, n (%)a | 28 (70.0) | 25 (62.5) | 0.48 |
Age (years) b | 67 (55–74) | 62 (57–64) | 0.13 |
Etiology, n (%) | N/A | ||
Pneumonia | 25 (62.5) | ||
Abdominal infection | 15 (37.5) | ||
Underlying diseases, n (%) | N/A | ||
Hypertension | 18 (45.0) | ||
Chronic respiratory disease | 2 (5.0) | ||
PaO2/FiO2 ratio, n (%) | N/A | ||
200–300 | 8 (20.0) | ||
100–200 | 20 (50.0) | ||
≦100 | 12 (30.0) | ||
CRP (mg/dl) | 12.0 (8.7–17.1) | N/A | |
PCT (ng/ml) | 2.7(0.7–18.4) | N/A | |
APACHE II score | 15 (11–24) | N/A | |
SOFA score | 7 (4–10) | N/A | |
Complications, n (%) | N/A | ||
Liver disfunction | 20 (50.0) | ||
Acute kidney injury | 7 (17.5) | ||
Treatment during ICU, n (%) | N/A | ||
Vasopressor | 24 (60.0) | ||
Parenteral nutrition | 18 (45.0) | ||
Sedative | 31 (77.5) | ||
IMV days | 16 (9–32) | N/A | |
28-day mortality, n (%) | 13 (32.5) | N/A |